心脏封堵器市场（2026—2031）
心脏封堵器市场规模预计由2026年的31.9亿美元增至2031年的65.6亿美元，预测期复合年增长率为15.52%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
心脏封堵器市场规模预计由2026年的31.9亿美元增至2031年的65.6亿美元，预测期复合年增长率为15.52%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 15.52% | 机构预测 |
| 市场规模 | 2026 | USD 3.19 billion | 机构预测 |
| 市场规模 | 2031 | USD 6.56 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| closure_type | congenital heart defect closure | 2025 | 46.650% |
| end_user | tertiary care hospitals | 2025 | 51.650% |
| geography | North America | 2025 | 44.280% |
| material | nitinol-based devices | 2025 | 51.870% |
| mode_of_delivery | transcatheter delivery | 2025 | 57.430% |
关键结论
- closure_type 维度中，congenital heart defect closure 在 2025 年的公开份额为 46.65%。
- end_user 维度中，tertiary care hospitals 在 2025 年的公开份额为 51.65%。
- geography 维度中，North America 在 2025 年的公开份额为 44.28%。
- material 维度中，nitinol-based devices 在 2025 年的公开份额为 51.87%。
- mode_of_delivery 维度中，transcatheter delivery 在 2025 年的公开份额为 57.43%。
主要参与者
- Abbott
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Lifetech Scientific Corporation
- Occlutech Holding AG
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising Structural Heart Disease And Atrial Fibrillation Burden | +4.500% | Global, highest in North America and high-SDI Europe | Long term (≥ 4 years) |
| Shift Toward Minimally Invasive Transcatheter Treatment | +3.800% | Global, especially North America, Western Europe, and urban Asia-Pacific centers | Medium term (2-4 years) |
| Stronger Clinical Evidence And Reimbursement Expansion | +3.200% | North America and the European Union, with effects in Asia-Pacific and the Middle East and Africa | Medium term (2-4 years) |
| Aging And Pediatric Congenital Heart Disease Populations | +2.200% | Global, with pediatric demand in South and East Asia and aging demand in Western Europe and Japan | Long term (≥ 4 years) |
| Procedure Planning With Intracardiac Echocardiography And Computational Imaging | +1.800% | Global, with earlier adoption in high-volume structural heart centers in North America, Europe, and Asia-Pacific | Medium term (2-4 years) |
| Biodegradable Occluders For Pediatric And Repeat-Intervention Use | +1.500% | Global, with stronger relevance in pediatric congenital heart disease centers in Asia-Pacific, Europe, and North America | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| High Upfront Device And Procedure Cost | -1.200% | Global, with the greatest constraint in the Middle East and Africa, South America, and Tier 2 and Tier 3 Asia-Pacific markets | Long term (≥ 4 years) |
| Device-Related Thrombus, Embolization, Effusion, And Atrial Fibrillation Risk | -0.900% | Global, particularly early-experience centers and settings with limited intensive care support | Medium term (2-4 years) |
| Operator Learning Curve And Imaging-Dependent Workflow | -1.100% | Global, especially lower-volume hospitals and emerging structural heart procedure centers | Medium term (2-4 years) |
| Nitinol And Specialized Component Supply Volatility | -0.800% | Global, with highest relevance across major medical device manufacturing and supply hubs | Medium term (2-4 years) |
报告关注的关键问题
What is the forecast value for heart closure devices market in 2031?
The heart closure devices market size is expected to grow from USD 2.76 billion in 2025 to USD 3.19 billion in 2026 and is forecast to reach USD 6.56 billion by 2031 at 15.52% CAGR over 2026-2031.
Which heart closure procedure is growing fastest?
Left atrial appendage closure is the fastest-growing closure type, with a projected 17.43% CAGR through 2031.
Why are transcatheter heart closure procedures expanding?
Transcatheter delivery held 57.43% share in 2025 and is forecast to grow at a 17.85% CAGR because it can reduce hospital stays and avoid open surgery in suitable cases.
Which settings are important for closure procedures?
Tertiary care hospitals led end-user demand with 51.65% share in 2025, while specialty heart clinics are forecast to grow at an 18.43% CAGR.
Which region is growing fastest for heart closure devices?
Asia-Pacific is projected to grow at a 16.54% CAGR through 2031, supported by procedure capacity, screening activity, and congenital heart disease demand.
What risks can limit adoption of closure devices?
High procedure costs, device-related thrombus, effusion, embolization, and uneven access to experienced clinical teams can limit adoption.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence